These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7141176)

  • 1. [Oral administration of delayed-action aminophylline: analysis of blood levels after multiple doses in aged patients].
    Guggino G; Ricca Rossellini S
    G Clin Med; 1982 May; 63(5):337-45. PubMed ID: 7141176
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of oral aminophylline on lung mucociliary clearance in man.
    Sutton PP; Pavia D; Bateman JR; Clarke SW
    Chest; 1981 Dec; 80(6 Suppl):889-92. PubMed ID: 7030662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic obstructive pulmonary disease with orally administered aminophylline].
    Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):265-8, 317-8. PubMed ID: 3233685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary study on the pharmacokinetics of aminophylline controlled-release tablets].
    Lin YG
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):1-3, 61. PubMed ID: 3197163
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 7. Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease.
    Vercelloni M; Cogo R; Albertini A; Granata M; Rosaschino F
    J Int Med Res; 1986; 14(3):131-6. PubMed ID: 3721053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial].
    Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H
    Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phyllocontin in chronic airflow obstruction.
    Dunn A; Hoffman N; Wilson RS
    Br J Clin Pract; 1984 Feb; 38(2):63-5. PubMed ID: 6367798
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of the determination of serum aminophylline levels].
    Xia XR; Kang XM; Tang ZQ
    Zhonghua Nei Ke Za Zhi; 1985 Jul; 24(7):406-8, 446. PubMed ID: 4053802
    [No Abstract]   [Full Text] [Related]  

  • 13. Is aminophylline useful in chronic obstructive pulmonary disease? When should corticosteroids be used?
    Figueroa Lebrón R
    Bol Asoc Med P R; 1988 Sep; 80(9):340. PubMed ID: 3190844
    [No Abstract]   [Full Text] [Related]  

  • 14. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum concentration of aminophylline after rectal, oral and intravenous administration].
    Shohat J; Molcho M; Glazer I; Halkin H
    Harefuah; 1979 Jun; 96(11):622-4. PubMed ID: 520904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological availability of two theophylline preparations (author's transl)].
    Kaik G
    Prax Klin Pneumol; 1982 Jun; 36(6):294-6. PubMed ID: 7111181
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationship between blood aminophylline levels and the effect of aminophylline as a bronchodilator in CARD patients (chronic aspecific respiratory disease)].
    van der Kolk HG; Kreukniet J; Glerum JH
    Ned Tijdschr Geneeskd; 1969 Nov; 113(46):2040-6. PubMed ID: 5357991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study on the absorption of drugs after oral, rectal and parenteral administration. II. Theophylline preparations].
    Kerckhoffs HP; Huizinga T
    Pharm Weekbl; 1967 Dec; 102(48):1255-68. PubMed ID: 5585650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spirographic indicators and theophylline levels in the blood and saliva after oral administration of 2 euphylline preparations in patients with reversible bronchial obstruction].
    Biernacki W; Bestry-Fus I; Figielski G
    Pneumonol Pol; 1982 Dec; 50(12):647-52. PubMed ID: 7182819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.